A Study to Investigate the Safety, Tolerability and Pharmacokinetics of OZ439 in Healthy Male and Female Subjects

NCT00928083 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Malaria Falciparum
Malaria Vivax
Healthy Volunteers

Interventions

DRUG: OZ439 50mg API capsules
DRUG: OZ439 200mg API capsules
DRUG: OZ439 400mg aqueous dispersion
DRUG: OZ439 800mg aqueous dispersion
DRUG: OZ439 100mg API capsules
DRUG: OZ439 400mg API capsules
DRUG: OZ439 1600mg aqueous dispersion
DRUG: OZ439 800mg API capsules
DRUG: OZ439 1200mg API capsules
DRUG: Placebo
DRUG: OZ439 200mg aqueous dispersion

Sponsor

Medicines for Malaria Venture